The introduction of any new therapeutic approach or management technique is frequently followed by a flurry of enthusiasm. This is especially true in the management of schizophrenia and psychotic disorders, in which the level of associated disability can be high. It is important to justify this enthusiasm, however; and new therapies need to be shown to have enduring beneficial effects in a disorder that will have a lifetime impact on the sufferer and his or her family.
No takes yet. Share an insight, caveat, or question.
Tarrier et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: